Justin File - MEI Pharma CFO Secretary
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
CFO
Justin File is CFO Secretary of MEI Pharma
| Age | 54 |
| Phone | 858 369 7100 |
| Web | https://meipharma.com |
MEI Pharma Management Efficiency
The company has return on total asset (ROA) of (0.2323) % which means that it has lost $0.2323 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8974) %, meaning that it created substantial loss on money invested by shareholders. MEI Pharma's management efficiency ratios could be used to measure how well MEI Pharma manages its routine affairs as well as how well it operates its assets and liabilities.MEI Pharma currently holds 8.36 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. MEI Pharma has a current ratio of 6.7, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about MEI Pharma's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 1 records | CFO Age | ||
| Giuliano Fratta | COSCIENS Biopharma | N/A | |
Management Performance
| Return On Equity | -0.9 | |||
| Return On Asset | -0.23 |
MEI Pharma Leadership Team
Elected by the shareholders, the MEI Pharma's board of directors comprises two types of representatives: MEI Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEI. The board's role is to monitor MEI Pharma's management team and ensure that shareholders' interests are well served. MEI Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEI Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Justin CPA, CFO CEO | ||
| BA Esq, COO Counsel | ||
| Anne Frese, Chief Officer | ||
| Eugene Park, VP Marketing | ||
| Virginia Sankey, VP Fin | ||
| JD Esq, Chief Officer | ||
| Eric Deng, VP Operations | ||
| Richard Ghalie, Chief Officer | ||
| MBA MD, Chief Officer | ||
| LLM JD, Senior Affairs | ||
| Robert Mass, Chief Medical Officer | ||
| BA CPA, CFO Sec | ||
| Robert MD, Strategic Advisor | ||
| Justin File, CFO Secretary | ||
| Nicole Iida, Vice Affairs | ||
| Daniel Gold, CEO and President and Director | ||
| Yomara GomezNaiden, Senior Quality |
MEI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEI Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.9 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | 59.84 M | |||
| Shares Outstanding | 32.84 M | |||
| Shares Owned By Insiders | 7.60 % | |||
| Shares Owned By Institutions | 8.12 % | |||
| Number Of Shares Shorted | 2.46 M | |||
| Price To Earning | 30.29 X | |||
| Price To Book | 5.02 X | |||
| Price To Sales | 0.27 X |
Pair Trading with MEI Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against MEI Stock
| 0.79 | APVO | Aptevo Therapeutics | PairCorr |
| 0.73 | NIVF | NewGenIvf Group | PairCorr |
| 0.71 | TRNR | Interactive Strength | PairCorr |
| 0.51 | AFIIQ | Armstrong Flooring | PairCorr |
| 0.39 | BRK-A | Berkshire Hathaway Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to MEI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEI Pharma to buy it.
The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in MEI Stock
If you are still planning to invest in MEI Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEI Pharma's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |